Under the program established under subsection (a), the Secretary shall provide for the application of the provisions described in paragraph (2) to value-based purchasing arrangements relating to drugs administered in the inpatient setting in a manner similar to the manner in which such provisions would apply if such drugs were administered in an outpatient setting. (2) Provisions described The provisions described in this paragraph are as follows: (A) Quarterly price reporting obligation Section 1927(b)(3)(E). (B) Definition of best price Clauses (i)(VII) and (ii)(V) of section 1927(c)(1)(C). (C) Definition of average manufacturer price Subparagraphs (B)(i)(VI) and (D) of section 1927(k)(1). (D) Anti-kickback and physician self-referral safe harbors Section 1128B(b)(3)(L) and section 1877(h)(1)(C)(iv). (c) Carve-Out of drugs In the case of a drug that is sold under a value-based purchasing arrangement, the Secretary shall permit States to pay for such drug under the terms and conditions of the arrangement separately from other inpatient items and services furnished to the individual. (d) Multi-State agreements Under the program established under subsection (a), the Secretary shall permit multiple States to enter into agreements with one another and with manufacturers which permit the transfer of funds between the participating states so that individuals who reside in a State different from the State in which they receive a drug subject to an value-based purchasing arrangement as an inpatient may be treated as if they received such drug in the State in which they reside. (e) Construction Nothing in this subparagraph shall be construed as deeming a drug furnished to an inpatient as being subject to the drug discount program under section 340B of the Public Health Service Act. . 6. Remuneration in Federal health care programs Section 1128B(b)(3) of the Social Security Act (42 U.S.C. 1320a–7b(b)(3)) is amended— (1) in subclause (J)— (A) by moving the left margin of such subparagraph 2 ems to the left